US Capitol Capsule: Cell-based, recombinant shots new plan of attack against H7N9
This article was originally published in Scrip
Executive Summary
Unlike in 2009, when a new type of influenza began spreading worldwide, known as the H1N1 swine-origin influenza A virus, if the situation gets to the point in which immunization is necessary for A(H7N9), a novel strain of bird flu identified in China in late March – with the number of human cases growing from three to 21 within the first week of the initial reports to the World Health Organization (WHO) – in 2013, there are newer, quicker ways to make a vaccine.